Cosmecca Korea Co., Ltd.

KOSDAQ:A241710 Stock Report

Market Cap: ₩729.4b

Cosmecca Korea Valuation

Is A241710 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Future Cash Flow Value

What is the Fair Price of A241710 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Ultimate guide to DCF valuation for stock investing

Learn how to determine fair value like the best investors in the world.

Below Fair Value: A241710 (₩67000) is trading below our estimate of fair value (₩177897.62)

Significantly Below Fair Value: A241710 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for A241710?

Key metric: As A241710 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for A241710. This is calculated by dividing A241710's market cap by their current earnings.
What is A241710's PE Ratio?
PE Ratio15.7x
Earnings₩45.49b
Market Cap₩729.44b

Price to Earnings Ratio vs Peers

How does A241710's PE Ratio compare to its peers?

The above table shows the PE ratio for A241710 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average16.9x
A018290 VT
6.6x-22.05%₩576.7b
A161890 Kolmar Korea
13.3x21.28%₩1.5t
A352480 C&C International
26.7x47.07%₩425.4b
A200130 KOLMAR BNHLtd
21.1xn/a₩346.3b
A241710 Cosmecca Korea
15.7x18.15%₩729.4b

Price-To-Earnings vs Peers: A241710 is good value based on its Price-To-Earnings Ratio (15.7x) compared to the peer average (16.9x).

Historical Price to Earnings Ratio

Historical Price to Earnings Ratio compares a stock's price to its earnings over time. Higher ratios indicate that investors are willing to pay more for the stock.

Fetching historical data

Price to Earnings Ratio vs Industry

How does A241710's PE Ratio compare vs other companies in the KR Personal Products Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
A900120 CXI Healthcare Technology Group
1.3xn/aUS$10.28m
No more companies available in this PE range
A241710 15.7xIndustry Avg. 19.5xNo. of Companies5PE01632486480+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: A241710 is good value based on its Price-To-Earnings Ratio (15.7x) compared to the KR Personal Products industry average (19.5x).

Price to Earnings Ratio vs Fair Ratio

What is A241710's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

A241710 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio15.7x
Fair PE Ratio15.4x

Price-To-Earnings vs Fair Ratio: A241710 is expensive based on its Price-To-Earnings Ratio (15.7x) compared to the estimated Fair Price-To-Earnings Ratio (15.4x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst A241710 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current₩67,000.00
₩95,833.33
+43.03%
11.75%₩110,000.00₩64,000.00n/a12
Jan ’27₩66,600.00
₩95,833.33
+43.89%
11.75%₩110,000.00₩64,000.00n/a12
Dec ’26₩69,500.00
₩95,636.36
+37.61%
12.28%₩110,000.00₩64,000.00n/a11
Nov ’26₩66,100.00
₩88,500.00
+33.89%
14.37%₩110,000.00₩64,000.00n/a8
Oct ’26₩72,400.00
₩88,500.00
+22.24%
14.37%₩110,000.00₩64,000.00n/a8
Sep ’26₩60,800.00
₩84,428.57
+38.86%
19.55%₩110,000.00₩57,000.00n/a7
Aug ’26₩64,700.00
₩79,285.71
+22.54%
16.63%₩104,000.00₩57,000.00n/a7
Jul ’26₩60,500.00
₩72,500.00
+19.83%
11.86%₩84,000.00₩57,000.00n/a6
Jun ’26₩50,300.00
₩69,333.33
+37.84%
10.32%₩80,000.00₩57,000.00n/a6
May ’26₩43,250.00
₩75,333.33
+74.18%
16.47%₩90,000.00₩57,000.00n/a6
Apr ’26₩47,700.00
₩85,833.33
+79.94%
20.85%₩120,000.00₩65,000.00n/a6
Mar ’26₩40,100.00
₩89,000.00
+121.95%
20.22%₩120,000.00₩65,000.00n/a5
Feb ’26₩51,700.00
₩97,600.00
+88.78%
14.74%₩120,000.00₩80,000.00n/a5
Jan ’26₩55,300.00
₩103,600.00
+87.34%
11.41%₩120,000.00₩90,000.00₩66,600.005
Dec ’25₩50,300.00
₩101,333.33
+101.46%
11.77%₩120,000.00₩90,000.00₩69,500.006
Nov ’25₩77,700.00
₩107,333.33
+38.14%
11.87%₩120,000.00₩90,000.00₩66,100.006
Oct ’25₩91,800.00
₩107,333.33
+16.92%
11.87%₩120,000.00₩90,000.00₩72,400.006
Sep ’25₩78,300.00
₩102,500.00
+30.91%
12.67%₩120,000.00₩90,000.00₩60,800.004
Aug ’25₩80,100.00
₩93,250.00
+16.42%
4.38%₩100,000.00₩90,000.00₩64,700.004
Jul ’25₩80,600.00
₩91,000.00
+12.90%
1.55%₩93,000.00₩90,000.00₩60,500.003
Jun ’25₩61,600.00
₩70,000.00
+13.64%
20.20%₩90,000.00₩60,000.00₩50,300.003
May ’25₩35,650.00
₩56,500.00
+58.49%
6.19%₩60,000.00₩53,000.00₩43,250.002
Apr ’25₩38,200.00
₩58,500.00
+53.14%
2.56%₩60,000.00₩57,000.00₩47,700.002
Mar ’25₩38,250.00
₩58,500.00
+52.94%
2.56%₩60,000.00₩57,000.00₩40,100.002
Feb ’25₩37,700.00
₩57,500.00
+52.52%
4.35%₩60,000.00₩55,000.00₩51,700.002
Jan ’25₩36,300.00
₩52,500.00
+44.63%
4.76%₩55,000.00₩50,000.00₩55,300.002
₩95.83k
Fair Value
30.1% undervalued intrinsic discount
12
Number of Analysts

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/01/15 15:32
End of Day Share Price 2026/01/15 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Cosmecca Korea Co., Ltd. is covered by 18 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hyeryeong KimCGS International
Han-sol JungDaishin Securities Co. Ltd.
Na Young ParkDaiwa Securities Co. Ltd.